Cost-effectiveness Analysis of Routine Screening Using Massively Parallel Sequencing for Maturity-Onset Diabetes of the Young in a Pediatric Diabetes Cohort: Reduced Health System Costs and Improved Patient Quality of Life.

Stephanie R JohnsonHannah E CarterPaul LeoSamantha A HollingworthElizabeth A DavisTimothy W JonesLouise S ConwellMark HarrisMatthew A BrownNicholas GravesEmma L Duncan

Published in: Diabetes care (2018)

Routine MPS screening for MODY in the pediatric population with diabetes could reduce health system costs and improve patient QoL. Our results make a compelling argument for routine genetic screening in all children with presumed type 1 diabetes mellitus.

Keyphrases

glycemic control
type diabetes
cardiovascular disease
clinical practice
case report
young adults
single cell
dna methylation
weight loss
cardiovascular risk factors
middle aged